Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries
dc.authorscopusid | 6603762543 | |
dc.authorscopusid | 7102733479 | |
dc.authorscopusid | 7202508291 | |
dc.authorscopusid | 57221557200 | |
dc.authorscopusid | 24073322700 | |
dc.authorscopusid | 36667245900 | |
dc.authorscopusid | 36868016000 | |
dc.contributor.author | Rosenthal, Victor D. | |
dc.contributor.author | Maki, Dennis G. | |
dc.contributor.author | Rodrigues, Camila | |
dc.contributor.author | Álvarez-Moreno, Carlos | |
dc.contributor.author | Leblebicioglu, Hakan | |
dc.contributor.author | Sobreyra-Oropeza, Martha | |
dc.contributor.author | Berba, Regina | |
dc.date.accessioned | 2024-09-25T19:45:15Z | |
dc.date.available | 2024-09-25T19:45:15Z | |
dc.date.issued | 2010 | |
dc.department | Abant İzzet Baysal Üniversitesi | en_US |
dc.description.abstract | BACKGROUND. The International Nosocomial Infection Control Consortium (INICC) was established in 15 developing countries to reduce infection rates in resource-limited hospitals by focusing on education and feedback of outcome surveillance (infection rates) and process surveillance (adherence to infection control measures). We report a time-sequence analysis of the effectiveness of this approach in reducing rates of central line-associated bloodstream infection (CLABSI) and associated deaths in 86 intensive care units with a minimum of 6-month INICC membership. METHODS. Pooled CLABSI rates during the first 3 months (baseline) were compared with rates at 6-month intervals during the first 24 months in 53,719 patients (190,905 central line-days). Process surveillance results at baseline were compared with intervention period data. RESULTS. During the first 6 months, CLABSI incidence decreased by 33% (from 14.5 to 9.7 CLABSIs per 1,000 central line-days). Over the first 24 months there was a cumulative reduction from baseline of 54% (from 16.0 to 7.4 CLABSIs per 1,000 central line-days; relative risk, 0.46 [95% confidence interval, 0.33-0.63]; P < .001). The number of deaths in patients with CLABSI decreased by 58%. During the intervention period, hand hygiene adherence improved from 50% to 60% (P < .001); the percentage of intensive care units that used maximal sterile barriers at insertion increased from 45% to 85% (P < .001 ), that adopted chlorhexidine for antisepsis increased from 7% to 27% (P=.018 ), and that sought to remove unneeded catheters increased from 37% to 83% (P=.004); and the duration of central line placement decreased from 4.1 to 3.5 days (P < .001). CONCLUSIONS. Education, performance feedback, and outcome and process surveillance of CLABSI rates significantly improved infection control adherence, reducing the CLABSI incidence by 54% and the number of CLABSI-associated deaths by 58% in INICC hospitals during the first 2 years. © 2010 by The Society for Healthcare Epidemiology of America. All rights reserved. | en_US |
dc.description.sponsorship | Federal University of Sao Paulo; INEN; Instituto Nacional de Enfermedades Neoplásicas; Medical College of Buenos Aires; National Hospital and Medical Research Centre; Society for Healthcare Epidemiology of America; The Society for Healthcare Epidemiology of America; University , Bogota , Colombia Ondokuz Mayis University; City, University of London, City; American University of Beirut; School of Medicine, Indiana University; Comisión de Investigaciones Científicas | en_US |
dc.identifier.doi | 10.1086/657140 | |
dc.identifier.endpage | 1272 | en_US |
dc.identifier.issn | 0899-823X | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 21029008 | en_US |
dc.identifier.scopus | 2-s2.0-78649944895 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1264 | en_US |
dc.identifier.uri | https://doi.org/10.1086/657140 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/12928 | |
dc.identifier.volume | 31 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Chicago Press | en_US |
dc.relation.ispartof | Infection Control and Hospital Epidemiology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | YK_20240925 | en_US |
dc.subject | chlorhexidine | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | antisepsis | en_US |
dc.subject | article | en_US |
dc.subject | bloodstream infection | en_US |
dc.subject | catheter | en_US |
dc.subject | clinical trial | en_US |
dc.subject | controlled study | en_US |
dc.subject | female | en_US |
dc.subject | health care organization | en_US |
dc.subject | health program | en_US |
dc.subject | health survey | en_US |
dc.subject | hospital infection | en_US |
dc.subject | human | en_US |
dc.subject | incidence | en_US |
dc.subject | intensive care unit | en_US |
dc.subject | International Nosocomial Infection Control Consortium | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | multicenter study | en_US |
dc.subject | treatment duration | en_US |
dc.title | Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries | en_US |
dc.type | Article | en_US |